News Novartis' psoriasis drug gets label boost New label shows Cosentyx is superior to J&J's rival in long-term.
News Cardiome antibiotic could reduce pressure on NHS Xydalba allows patients to be treated and quickly discharged.
News Valeant's Siliq price undercuts rivals to offset black box w... Siliq will be cheaper than rivals from Novartis and Eli Lilly.
News Sanofi/Regeneron eczema data paves way for year's biggest la... Companies look to take on Pfizer after series of setbacks.
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
